To assess the effectiveness of the synthetic analogue of prostacyclin in postembolic residual pulmonary hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
State Research Institute of Circulation Pathology
Novosibirsk, Russia
RECRUITINGPulmonary hypertension
The average pressure in the pulmonary artery trunk (according to direct tensiometry before Ventavis therapy, after the therapy according to transthoracic echocardiography and six months after discharge (transthoracic echocardiography).
Time frame: 6 months
Number of deaths
Time frame: 6 months
Number of recurrent pulmonary embolisms
Time frame: 6 months
Number of venous thromboembolisms
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.